Abbvie Inc
NYSE: ABBV
$193.47
-$0.15 (-0.1%)
Closing Price on September 20, 2024
ABBV Articles
The top analyst upgrades, downgrades and initiations seen on Tuesday include AbbVie, Frontier Communications, Hyatt Hotels and Weatherford International.
Published:
Last Updated:
Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
Published:
Last Updated:
A new Jefferies research report features its third big change for 2017. Plus four top dividend-paying stocks that long like great buys now.
Published:
Last Updated:
It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far the reaction has been quite positive.
Published:
Last Updated:
Jefferies has made a third big change for 2017 by adding Marathon Petroleum to the Franchise Picks list. Plus, three more top dividend-paying stocks from the list.
Published:
Last Updated:
AbbVie reported mixed fourth-quarter financial results and offered guidance before the markets opened on Friday.
Published:
Last Updated:
The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly down.
Published:
Last Updated:
The health care sector has some of its biggest players reporting later this week, with one pharma giant’s report already out of the way.
Published:
Last Updated:
A new Jefferies research report makes the case that while market parameters are indeed expensive, there still are cheap stocks to buy that have a large enough market cap to provide some safety.
Published:
Last Updated:
24/7 Wall St. has put together a preview of AT&T, AbbVie, Starbucks and some of the major companies scheduled to share their quarterly results in the coming days.
Published:
Last Updated:
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through...
Published:
Last Updated:
The December 15 short interest data have been compared with the previous figures, and short interest increased in most of these selected pharmaceutical stocks.
Published:
Last Updated:
A top new addition to the Franchise list portfolio and three additional dividend stocks that the Jefferies team views as their top high conviction picks.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected pharmaceutical stocks.
Published:
Last Updated:
With money expected to come out of the bond market, these four stocks are an attractive alternative that have solid upside potential, and they are the highest conviction picks at Jefferies.
Published:
Last Updated: